"The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces that the Sputnik V vaccine has been approved by the Ministry of Health of the Republic of Armenia," the fund said.
The decision was made based on data from phase III clinical trials in Russia without additional studies in Armenia, the RDIF noted.
The Sputnik V vaccine is currently registered in Russia, Belarus, Argentina, Bolivia, Serbia, Algeria, the Palestinian Authority, Venezuela, Paraguay, Turkmenistan, Hungary, UAE, Iran, Republic of Guinea and Tunisia.
